Maximum quantity allowed is 999
Please select the quantity
CAS RN: 177036-94-1 | Product Number: A2966
Ambrisentan
×
![]()
×
Purity: >98.0%(HPLC)
Synonyms:
- (S)-2-[(4,6-Dimethylpyrimidin-2-yl)oxy]-3-methoxy-3,3-diphenylpropionic Acid
Product Documents:
| Size | Unit Price | Hyderabad | Japan* | Quantity |
|---|---|---|---|---|
| 20MG |
₹3,500.00
|
Contact Us | 24 |
|
| 100MG |
₹7,900.00
|
1 | ≥60 |
|
*Upon orders receipt, Hyderabad stocks will be dispatched on the same day.
*Items available in Japan warehouse will be dispatched in 10-12 working days.
*INR price is exclusive of domestic taxes applicable.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
| Product Number | A2966 |
Purity / Analysis Method 
|
>98.0%(HPLC) |
| Molecular Formula / Molecular Weight | C__2__2H__2__2N__2O__4 = 378.43 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature
|
Room Temperature (Recommended in a cool and dark place, <15°C) |
| CAS RN | 177036-94-1 |
| PubChem Substance ID | 354333648 |
| Merck Index (14) | 384 |
| MDL Number | MFCD09842330 |
Specifications
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Specific rotation [a]20/D | +170 to +176 deg(C=0.5, MeOH) |
Properties (reference)
| Melting Point | 178 °C(dec.) |
| Specific Rotation | 173° (C=0.5,MeOH) |
| Solubility in water | Insoluble |
| Solubility (soluble in) | Ethanol, Acetone |
GHS
| Pictogram |
|
| Signal Word | Warning |
| Hazard Statements | H361 : Suspected of damaging fertility or the unborn child. |
| Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P202 : Do not handle until all safety precautions have been read and understood. P201 : Obtain special instructions before use. P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection. P308 + P313 : IF exposed or concerned: Get medical advice/ attention. P405 : Store locked up. |
Related Laws:
| RTECS# | UA2459660 |
Transport Information:
Application
Ambrisentan: A Selective ETA Receptor Antagonist
Endothelin-1 (ET-1) is a peptide that constricts pulmonary blood vessels and raise blood pressure. Two ET-1 receptor subtypes, ETA and ETB, mediate the effects of ET-1 in the vascular smooth muscle and endothelium. The actions of ETA would be vasoconstriction and cell proliferation, while the actions of ETB would be vasodilatation, antiproliferation, and ET-1 clearance. Ambrisentan is a highly selective ETA receptor antagonist with >4000-fold higher selectivity over the ETB receptor. Pulmonary arterial hypertension (PAH) would be derived from the action of ETA receptor. Therefore, ambrisentan is used for the treatment of PAH. For your reference, [H1568] is a key synthetic intermediate of ambrisentan. (The product is for research purpose only.)
References
- Discovery and Optimization of a Novel Class of Orally Active Nonpeptidic Endothelin-A Receptor Antagonists
- Endothelin receptor antagonists in congestive heart failure: a new therapeutic principle for the future?
- The endothelin system in pulmonary arterial hypertension
- Endothelin receptor antagonists in pulmonary arterial hypertension (a review)
- Ambrisentan (a review)
PubMed Literature
Product Articles
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.